Pay in 4 interest-free payments of $6.20 Learn more
Ships within 48 hours · Estimated delivery Aug 29 - Sep 3
2007;69(3):S619
First, understand why
The Phase IIb efficacy trials did not meet their efficacy endpoints, and clinical development for the original therapeutic indication was halted
BMC Endocr Disord 2010;10:7
Adjust your protocol based on ongoing assessment rather than following a rigid plan regardless of results
There may be other reasons why these medications are not right for you , including if you have severe side effects or certain underlying health conditions
US$ 20.72
US$ 21.16
US$ 25.56
US$ 20.55
US$ 28.91
US$ 27.41
US$ 29.17
US$ 23.07
